Open App
Company / Named in our posts

ARS Pharma.

Follow ARS Pharma

A biopharmaceutical company developing neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis.[1]

01Deal
01

Deals on Carrywatch

Every deal that names ARS Pharma, and its role in each.

Silverback / ARS Pharma

Silverback and ARS Pharma complete merger transaction

See deal details
02

Deal Web

ARS Pharma and 0 firms it shares a posted deal with, and the path to any other firm.

03

Financials

5 fiscal years of figures as ARS Pharma reported them.

04

News

Loading headlines.

05

Sources

As of 24 Oct 2026.

  1. 01
    Form 8-K

    U.S. Securities and Exchange Commission · Researched 24 Oct 2026

Deal posts naming ARS Pharma:

  1. P01